Jianhua Lu

Dr. Jianhua Lu

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2021 in Pathogens
Verified
Journal Article
Open access
PDF file
MLmiao li
miao li
YZYue Zhang
Yue Zhang
JLJianhua Lu
Jianhua Lu
LLLi Li
Li Li
HGHuixia Gao
Huixia Gao
EDErhei Dai
Erhei Dai
The sharp increase in the proportion of asymptomatic cases and the potential risk of virus transmission have greatly increased the difficulty of controlling the COVID-19 pandemic. The individual immune response is closely associated with clinical outcomes and pathogenic mechanisms of COVID-19. However, the clinical characteristics and immunophenotyping features of immune cells of asymptomatic individuals remain somewhat mysterious. To better understand and predict the disease state and progress, we performed a comprehensive analysis of clinical data, laboratory indexes and immunophenotyping features in 41 patients with SARS-CoV-2 (including 24 asymptomatic cases and 17 symptomatic individuals). Firstly, from the perspective of demographic characteristics, the rate of asymptomatic infection was significantly higher in those with younger age. Secondly, the laboratory test results showed that some indexes, such as CRP (acute phase reaction protein), D-Dimer and fibrinogen (the marker for coagulation) were lower in the asymptomatic group. Finally, symptomatic individuals were prone to establishing a non-protective immune phenotype by abnormally decreasing the lymphocyte count and percentage, abnormally increasing the Th17 percentage and decreasing Treg percentage, which therefore cause an increase in the neutrophil/lymphocyte ratio (NLR), monocytes/lymphocytes ratio (MLR) and Th17/Treg ratio. On the other hand, asymptomatic individuals tended to establish a more effective and protective immune phenotype by maintaining a normal level of lymphocyte count and percentage and a high level of NK cells. At the same time, asymptomatic individuals can establish a relatively balanced immune response through maintaining a low level of monocytes, a relatively low level of Th17 and high level of Treg, which therefore lead to a decrease in MNKR and Th17/Treg ratio and finally the avoidance of excessive inflammatory responses. This may be one of the reasons for their asymptomatic states. This study is helpful to reveal the immunological characteristics of asymptomatic individuals, understand immune pathogenesis of COVID-19 and predict clinical outcomes more precisely. However, owing to small sample sizes, a future study with larger sample size is still warranted.

10 September 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SPShengfei Pei
Shengfei Pei
LYLi Yang
Li Yang
HGHuixia Gao
Huixia Gao
YLYuzhen Liu
Yuzhen Liu
EDErhei Dai
Erhei Dai
JLJianhua Lu
Jianhua Lu
The escalating frequency of environmental pollution incidents has raised significant concerns regarding the potential health impacts of pollutant fluctuations. Consequently, a comprehensive study on the role of pollutants in the prevalence of viral hepatitis is indispensable for the advancement of innovative prevention strategies. Monthly incidence rates of viral hepatitis from 2005 to 2020 were sourced from the Chinese Center for Disease Control and Prevention Infectious Disease Surveillance Information System. Pollution data spanning 2014–2020 were obtained from the National Oceanic and Atmospheric Administration (NOAA), encompassing pollutants such as CO, NO2, and O3. Time series analysis models, including seasonal auto-regressive integrated moving average (SARIMA), Holt-Winters model, and Generalized Additive Model (GAM), were employed to explore prediction and synergistic effects related to viral hepatitis. Spearman correlation analysis was utilized to identify pollutants suitable for inclusion in these models. Concurrently, machine learning (ML) algorithms were leveraged to refine the prediction of environmental pollutant levels. Finally, a weighted quantile sum (WQS) regression framework was developed to evaluate the singular and combined impacts of pollutants on viral hepatitis cases across different demographics, age groups, and environmental strata. The incidence of viral hepatitis in Beijing exhibited a declining trend, primarily characterized by HBV and HCV types. In predicting hepatitis prevalence trends, the Holt-Winters additive seasonal model outperformed the SARIMA multiplicative model ((1,1,0) (2,1,0) [12]). In the prediction of environmental pollutants, the SVM model demonstrated superior performance over the GPR model, particularly with Polynomial and Besseldot kernel functions. The combined pollutant risk effect on viral hepatitis was quantified as βWQS (95% CI) = 0.066 (0.018, 0.114). Among different groups, PM2.5 emerged as the most sensitive risk factor, notably impacting patients with HCV and HEV, as well as individuals aged 35–64. CO predominantly affected HAV patients, showing a risk effect of βWQS (95% CI) = − 0.0355 (− 0.0695, − 0.0016). Lower levels of PM2.5 and PM10 were associated with heightened risk of viral hepatitis incidence with a lag of five months, whereas elevated levels of PM2.5 (100–120 μg/m3) and CO correlated with increased hepatitis incidence risk with a lag of six months. The Holt-Winters model outperformed the SARIMA model in predicting the incidence of viral hepatitis. Among machine learning algorithms, SVM and GPR models demonstrated superior performance for analyzing pollutant data. Patients infected with HAV and HEV were primarily influenced by PM10 and CO, whereas SO2 and PM2.5 significantly impacted others. Individuals aged 35–64 years appeared particularly susceptible to these pollutants. Mixed pollutant exposures were found to affect the development of viral hepatitis with a notable lag of 5–6 months. These findings underscore the importance of long-term monitoring of pollutants in relation to viral hepatitis incidence.

11 August 2025 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
YSYuzhu Shi
Yuzhu Shi
YXYuchen Xie
Yuchen Xie
YCYing Chen
Ying Chen
LYLi Yang
Li Yang
HGHuixia Gao
Huixia Gao
EDEr-Hei Dai
Er-Hei Dai
Introduction: Hepatitis B virus (HBV) infection poses a major global public health challenge. Recent studies have highlighted the clinical implications of coinfection with the hepatitis E virus (HEV) in HBV-infected individuals, as this dual infection is associated with exacerbated disease severity. However, epidemiological data on HBV/HEV coinfection in the Hebei region are scarce, necessitating further investigation.Methods: We conducted a multicenter cross-sectional study for infectious diseases across six tertiary hospitals. Serum samples were screened for anti-HEV IgM and IgG antibodies by using an automated chemiluminescent immunoassay. Samples positive for anti-HEV antibodies were further subjected to HEV RNA detection using the reverse transcription polymerase chain reaction (RT-PCR). The seroprevalence of anti-HEV antibodies was 18.70% (582/3,113).Results: Among these, 562 cases were positive for anti-HEV IgG, 4 were positive for anti-HEV IgM, and 16 were positive for both anti-HEV IgG and IgM. HEV RNA was detected in 16 (2.75%; 582) anti-HEV-seropositive individuals. A strong positive correlation was observed between anti-HEV seroprevalence and advancing age [R2 = 0.966 in the liver cirrhosis (LC) group, R2 = 0.774 in the hepatocellular carcinoma (HCC) group, and R2 = 0.508 in the chronic hepatitis B (CHB) group]. Multivariate analysis confirmed that older age was an independent risk factor for anti-HEV seropositivity (OR = 1.03, 95% CI: 1.02–1.04, P < 0.001). HBV mono-infection patients were significantly younger than those with HBV and acute HEV coinfection patients or HBV with previous HEV infection patients (53.0 vs. 58.5 vs. 58.0 years, P < 0.001). Additionally, LC and HCC were more prevalent in the HBV with previous HEV infection than in HBV mono-infection (65.98% vs. 77.27%, P < 0.001). Compared to HBV mono-infection patients, the activated partial thromboplastin time was significantly prolonged in both HBV and HEV acute coinfection patients and in those with HBV and previous HEV infection (32.30 s vs. 35.65 s vs. 34.46 s, P < 0.05).Discussion: Our findings demonstrated an 18.70% seroprevalence of anti-HEV antibodies among chronically HBV-infected patients in the Hebei Province, with a significantly higher risk of coinfection in older individuals. HBV/HEV coinfection may aggravate liver injury and impair coagulation. These results provide valuable insights into the epidemiology and clinical consequences of HBV/HEV coinfection in this region.

7 June 2026 in Virus Research
Verified
Journal Article
Open access
YSYuzhu Shi
Yuzhu Shi
YXYuchen Xie
Yuchen Xie
YCYing Chen
Ying Chen
XGXinru Guo
Xinru Guo
LYLi Yang
Li Yang
EDEr-Hei Dai
Er-Hei Dai
This study aimed to analyze serum HBV RNA levels in HBsAg-positive patients with persistent viremia undergoing nucleos(t)ide analog (NAs) therapy for over 48 weeks and to examine the clinical characteristics of HBV RNA-positive patients. In this cross-sectional study, 277 patients with complete virological response (CVR) and 277 patients with persistent viral positivity (PV) were included, with confounders balanced using 1:1 propensity score matching (PSM). Serum HBV RNA levels were quantified using a PCR-fluorescent probe assay, with a lower limit of quantification of 100 copies/mL. Patients in the PV group were classified into RNA-negative (<100 copies/mL) and RNA-positive (≥100 copies/mL) subgroups based on RNA levels. The HBV RNA-positive rate was significantly higher in the PV group than in the CVR group (P < 0.001). Multivariable regression analysis identified ALT, AST, HBsAg level, HBeAb status, and HBV RNA status as independent predictors of HBV DNA positivity. ALT levels were significantly higher in HBV RNA-positive patients, and the prevalence of cirrhosis and splenomegaly was notably higher in the RNA-positive group (P < 0.05), suggesting more severe liver damage. HBV RNA status was positively associated with HBsAg, HBeAg, and HBV DNA positivity. HBV RNA status is an important marker of viral replication activity and liver injury, particularly in PV patients. Monitoring HBV RNA status as a non-invasive biomarker may help assess disease progression and inform patient management.